This suggests that GPAA1 may contribute to CRC progression not only through direct effects on tumor cell behavior but also by promoting genomic instability, which could accelerate tumor evolution and therapeutic resistance (14). The gene discussed is GPAA1; the disease is colorectal carcinoma.